Mobile

Randomised, double-blind, placebo-controlled, parallel-group trial to investigate the analgesic effect of OROS hydromorphone hydrochloride in comparison with placebo in subjects with moderate to sever...

Mise à jour : Il y a 4 ans
Référence : EUCTR2006-006911-60

Randomised, double-blind, placebo-controlled, parallel-group trial to investigate the analgesic effect of OROS hydromorphone hydrochloride in comparison with placebo in subjects with moderate to severe pain induced by osteoarthritis of the hip or the knee

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To compare the analgesic effect of OROS hydromorphone hydrochloride with placebo in subjects with moderate to severe pain induced by osteoarthritis (OA) of the hip or knee which has not been adequately controlled by previous treatment with nonsteroidal anti-inflammatory drugs (NSAIDs) or paracetamol. This will be assessed by the Brief Pain Inventory (BPI) item 5 “pain on average”.

Critère d'inclusion

  • moderate to severe pain induced by osteoarthritis of the hip or the knee

Liens